Corporate insiders and private money
LEVY BRIAN
- SEC filer ID (CIK)
- 1277458 EDGAR ↗
| Filed | Form | Company | Role | Sold | Bought | Filing |
|---|---|---|---|---|---|---|
| 2016-02-11 | 4 | Ocata Therapeutics, Inc. OCAT | Director | EDGAR ↗ | ||
| 2016-01-04 | 4 | Ocata Therapeutics, Inc. OCAT | Director | EDGAR ↗ | ||
| 2015-11-04 | 4 | INSITE VISION INC INSV | Director | EDGAR ↗ | ||
| 2015-10-01 | 4 | Ocata Therapeutics, Inc. OCAT | Director | EDGAR ↗ | ||
| 2015-09-10 | 4 | Ocata Therapeutics, Inc. OCAT | Director | EDGAR ↗ | ||
| 2015-08-31 | 3 | Ocata Therapeutics, Inc. OCAT | Director | EDGAR ↗ | ||
| 2015-02-27 | 4 | AERIE PHARMACEUTICALS INC AERI | Officer Chief Medical Officer | EDGAR ↗ | ||
| 2014-12-12 | 4 | INSITE VISION INC INSV | Director | EDGAR ↗ | ||
| 2014-03-17 | 4 | AERIE PHARMACEUTICALS INC AERI | Officer Chief Medical Officer | EDGAR ↗ | ||
| 2013-12-13 | 4 | INSITE VISION INC INSV | Director | EDGAR ↗ | ||
| 2013-11-01 | 4 | AERIE PHARMACEUTICALS INC AERI | Officer Chief Medical Officer | $60,000 | EDGAR ↗ | |
| 2013-10-25 | 3 | AERIE PHARMACEUTICALS INC AERI | Officer Chief Medical Officer | EDGAR ↗ | ||
| 2012-12-14 | 4 | INSITE VISION INC INSV | Director | EDGAR ↗ | ||
| 2011-12-21 | 4 | INSITE VISION INC INSV | Director | EDGAR ↗ | ||
| 2011-09-20 | 4 | INSITE VISION INC INSV | Director | EDGAR ↗ | ||
| 2011-09-20 | 3 | INSITE VISION INC INSV | Director | EDGAR ↗ | ||
| 2007-10-30 | 4 | BAUSCH & LOMB INC BOL | Officer Vice President | EDGAR ↗ | ||
| 2007-08-16 | 4 | BAUSCH & LOMB INC BOL | Officer Vice President | EDGAR ↗ | ||
| 2007-07-24 | 4 | BAUSCH & LOMB INC BOL | Officer Vice President | EDGAR ↗ | ||
| 2007-05-10 | 4 | BAUSCH & LOMB INC BOL | Officer Vice President | EDGAR ↗ | ||
| 2007-02-26 | 4 | BAUSCH & LOMB INC BOL | Officer Vice President | EDGAR ↗ | ||
| 2007-02-15 | 4 | BAUSCH & LOMB INC BOL | Officer Vice President | EDGAR ↗ | ||
| 2006-11-09 | 4 | BAUSCH & LOMB INC BOL | Officer Vice President | EDGAR ↗ | ||
| 2006-08-17 | 4 | BAUSCH & LOMB INC BOL | Officer Vice President | EDGAR ↗ | ||
| 2006-05-12 | 4 | BAUSCH & LOMB INC BOL | Officer Vice President | EDGAR ↗ | ||
| 2006-02-17 | 4 | BAUSCH & LOMB INC BOL | Officer Vice President | EDGAR ↗ |
Sold and Bought: shares times price for open-market sales and purchases on that filing.
Insider trades
| Company | Sold | Bought | Trades | Dates |
|---|---|---|---|---|
| AERIE PHARMACEUTICALS INC | $60,000 | 1 | 2013-10-30 |
| Date | Company | Trade | Shares | Price | Total | Notes | Filing |
|---|---|---|---|---|---|---|---|
| 2013-10-30 | AERIE PHARMACEUTICALS INC AERI | Purchase | 6,000 | $10.00 | $60,000 | Form 4 ↗ |
Open-market sales (code S) and purchases (code P) reported on Form 4, at the reported price. 10b5-1 plan: the filing says the trades were made under a prearranged trading plan (the Form 4 checkbox from 2023, or a footnote).